Biography and Research Information
OverviewAI-generated summary
Shivi Jain's research focuses on various aspects of women's health and hematological disorders. Her work includes investigating diagnostic methods for conditions such as genital tuberculosis, adenomyosis, and polycystic ovarian syndrome (PCOS) in women, with a particular interest in age-specific parameters and correlations between clinical, hormonal, and ultrasound findings. Jain also studies immune thrombocytopenia and has explored novel treatments and efficacy analyses for related medications. Her publications include work on the uncommon presentation and management of post-transfusion purpura and hyperhemolysis in sickle cell disease, highlighting the complexities of blood disorders. Additionally, her research extends to the role of diffusion-weighted magnetic resonance imaging in predicting treatment response for breast cancer and its molecular subtypes. Jain has published over 113 papers, with an h-index of 16 and 859 citations, and collaborates with researchers at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 16
- Publications: 106
- Citations: 850
Selected Publications
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
Collaboration Network
Top Collaborators
- Diagnosis of Genital Tuberculosis in Infertile Women by Using the Composite Reference Standard
- Correlation of Clinical, Hormonal, Biochemical and Ultrasound Parameters Between Adult and Adolescent Polycystic Ovarian Syndrome
- Diagnostic Role of Transvaginal Sonography and Magnetic Resonance Imaging in Adenomyosis of the Uterus and its Correlation with Histopathology
- Age-Specific Nomograms for Antral Follicle Count in Fertile and Infertile Indian Women: A Comparative Study
- A Correlation between Antral Follicle Count and Anti-Müllerian Hormone in Healthy Indian Women of Reproductive Age
Showing 5 of 6 shared publications
- Impact of blood type on thrombosis and disease severity in adult COVID-19 patients
- Prevention of Thromboembolic Events in Patients with COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Heparin Induced Thrombocytopenia in Patients with COVID-19
- Impact of blood type on thrombosis and disease severity in adult COVID-19 patients
- Prevention of Thromboembolic Events in Patients with COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Heparin Induced Thrombocytopenia in Patients with COVID-19
- Impact of blood type on thrombosis and disease severity in adult COVID-19 patients
- Prevention of Thromboembolic Events in Patients with COVID-19
- Heparin Induced Thrombocytopenia in Patients with COVID-19
- Impact of blood type on thrombosis and disease severity in adult COVID-19 patients
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Diagnostic Role of Transvaginal Sonography and Magnetic Resonance Imaging in Adenomyosis of the Uterus and its Correlation with Histopathology
- Age-Specific Nomograms for Antral Follicle Count in Fertile and Infertile Indian Women: A Comparative Study
- A Correlation between Antral Follicle Count and Anti-Müllerian Hormone in Healthy Indian Women of Reproductive Age
- Diagnosis of Genital Tuberculosis in Infertile Women by Using the Composite Reference Standard
- A Prospective Observational Study Comparing Contrast-Enhanced Ultrasonography (CEUS) and Magnetic Resonance Imaging (MRI) in Evaluating Adnexal Lesions
- Contrast-enhanced Ultrasonography vs Magnetic Resonance Imaging in the Evaluation of Uterine Lesions: A Prospective Observational Study
- Prevention of Thromboembolic Events in Patients with COVID-19
- Heparin Induced Thrombocytopenia in Patients with COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
- Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
- Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
Similar Researchers
Based on overlapping research topics